Literature DB >> 9715216

A review of carisoprodol deaths in Jefferson County, Alabama.

G G Davis1, C B Alexander.   

Abstract

BACKGROUND: Carisoprodol is a skeletal muscle relaxant with the potential for abuse. A carisoprodol overdose is rarely considered fatal. Nevertheless, we encountered carisoprodol in several cases, prompting review of our experience.
METHODS: We did a retrospective study of cases examined at the Jefferson County Coroner/Medical Examiner Office from January 1, 1986, to October 31, 1997, reviewing investigative reports and autopsy findings.
RESULTS: Carisoprodol was present in 24 cases. Seventeen decedents died of acute drug intoxication. Carisoprodol was never the sole drug detected at autopsy, nor was it ever the sole cause of death. Propoxyphene was a co-intoxicant in 8 of the 24 cases.
CONCLUSIONS: Carisoprodol causes respiratory depression. Since the mechanism of death was respiratory depression in 82% of the decedents who died of acute intoxication, we consider that carisoprodol was probably responsible, in part, for those deaths. The simultaneous use of propoxyphene and carisoprodol seems to be especially dangerous.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9715216     DOI: 10.1097/00007611-199808000-00004

Source DB:  PubMed          Journal:  South Med J        ISSN: 0038-4348            Impact factor:   0.954


  3 in total

1.  Carisoprodol intoxications: a retrospective study of forensic autopsy material from 1992-2003.

Authors:  Gudrun Høiseth; Jørgen G Bramness; Asbjørg S Christophersen; Jørg Mørland
Journal:  Int J Legal Med       Date:  2006-11-18       Impact factor: 2.686

2.  CYP2C19 genetics in fatal carisoprodol intoxications.

Authors:  Gudrun Høiseth; Umair Majid; Jørg Mørland; Jørgen G Bramness; Espen Molden
Journal:  Eur J Clin Pharmacol       Date:  2012-04-15       Impact factor: 2.953

3.  Carisoprodol abuse in Texas, 1998-2003.

Authors:  Mathias B Forrester
Journal:  J Med Toxicol       Date:  2006-03
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.